• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    OptumInsight and Change Healthcare Combine to Advance a More Modern, Information and Technology-Enabled Health Care Platform

    1/6/21 6:00:00 AM ET
    $UNH
    $CHNG
    Medical Specialities
    Health Care
    Managed Health Care
    Health Care
    Get the next $UNH alert in real time by email

    EDEN PRAIRIE, Minn. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Optum, a diversified health services company and part of UnitedHealth Group (NYSE: UNH), and Change Healthcare (NASDAQ: CHNG), a health care technology leader, have agreed to combine. Change Healthcare will join with OptumInsight to provide software and data analytics, technology-enabled services and research, advisory and revenue cycle management offerings to help make health care work better for everyone.

    This combination unites two technology and service companies focused on serving health care. Their combined capabilities will more effectively connect and simplify core clinical, administrative and payment processes - resulting in better health outcomes and experiences for everyone, at lower cost. Change Healthcare brings key technologies, connections and advanced clinical decision, administrative and financial support capabilities, enabling better workflow and transactional connectivity across the health care system. Optum brings modern analytics, comprehensive clinical expertise, innovative technologies and extensive experience in improving operational and clinical performance.

    “Together we will help streamline and inform the vital clinical, administrative and payment processes on which health care providers and payers depend to serve patients,” said Andrew Witty, President of UnitedHealth Group and CEO of Optum. “We’re thrilled to welcome Change Healthcare’s highly skilled team to create a better future for health care.”

    “This opportunity is about advancing connectivity and accelerating innovations and efficiencies essential to a simpler, more intelligent and adaptive health system. We share with Optum a common mission and values and importantly, a sense of urgency to provide our customers and those they serve with the more robust capacities this union makes possible,” said Neil de Crescenzo, President and CEO of Change Healthcare. Upon closing, Mr. de Crescenzo will serve as OptumInsight’s chief executive officer, leading the combined organization.

    Some of the key opportunities to enhance the health care system include:

    • The combined company will help clinicians make the most informed and clinically advanced patient care decisions, more quickly and easily. Change Healthcare brings widely adopted technology for integrating evidence-based clinical criteria directly into the clinician’s workflow, while Optum’s clinical analytics expertise and Individual Health Record can strengthen the evidence base needed to deliver effective clinical decision support at the point of care. This can ensure appropriate sites of care and consistently achieve the best possible health, quality and cost outcomes.
    • Complexities across the health system result in significant levels of administrative waste. The combined company will be well positioned to make health care simpler, more efficient and more effective. A key opportunity is to enhance with insights drawn from billions of claims transactions using Change Healthcare’s intelligent health care network, combined with Optum’s advanced data analytics. This will support significantly faster, more informed and accurate services and processing.
    • Change Healthcare’s payment capacities combined with Optum’s highly automated payment network will simplify financial interactions among care providers, payers and consumers and accelerate the movement to a more modern, real-time and transparent payment system. This will ensure physicians get paid more quickly, accurately and reliably, and provide consumers the same simplicity and convenience managing their health care finances they experience with other transactions. Change Healthcare brings deep patient communication capabilities, engaging more than 200 million unique individuals each year. Integrating these engagements with people’s health financial benefits will make it simpler for consumers and enhance alignment with incentive programs which reward healthy behaviors.

    “Change Healthcare has made significant progress executing its strategic objectives, including advancing innovation, accelerating growth and improving the effectiveness of the U.S. health system,” said Howard Lance, Chairman of the Board of Directors of Change Healthcare. “We are delighted to have in Optum a partner that shares a common vision of creating a better future for health care for the people and communities we serve and see this combination as in the best interests of all of our stakeholders.”

    The agreement calls for the acquisition of Change Healthcare’s common stock for $25.75 per share in cash and is expected to close in the second half of 2021, subject to Change Healthcare shareholders’ approval, regulatory approvals and other customary closing conditions. Private equity funds affiliated with The Blackstone Group, which own approximately 20% of the common stock of Change Healthcare, have agreed to vote the shares they control in favor of the combination.

    The acquisition is expected to be accretive to UnitedHealth Group’s net and adjusted earnings per share by approximately $0.20 and $0.50 respectively in 2022, advancing strongly in subsequent years, inclusive of investments to accelerate technology, system and product integration and development activities to more quickly deliver the value of this combination to all health care system stakeholders. Adjusted earnings exclude from net earnings only the after-tax non-cash amortization expense pertaining to acquisition-related intangible assets.

    About Optum

    Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 190,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group (NYSE: UNH). For more information, visit www.Optum.com.

    About Change Healthcare

    Change Healthcare (NASDAQ: CHNG) is a leading independent healthcare technology company, focused on accelerating the transformation of the healthcare system through the power of the Change Healthcare Platform. We provide data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system. Learn more at www.changehealthcare.com.

    Additional Information and Where to Find It

    The proposed transaction will be submitted to the stockholders of CHNG for their consideration. This communication may be deemed to be solicitation material in connection with the proposed transaction. UNH and CHNG intend to file materials relevant to the proposed transaction with the SEC, including CHNG’s proxy statement on Schedule 14A. This communication is not a substitute for the proxy statement or any other documents that CHNG may send to its stockholders in connection with the proposed transaction. BEFORE MAKING ANY VOTING DECISIONS, CHNG’s STOCKHOLDERS ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE, INCLUDING THE PROXY STATEMENT FOR THE PROPOSED TRANSACTION, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Copies of the proxy statement and other relevant materials, when filed, will be available free of charge on the SEC’s web site at http://www.sec.gov or on CHNG’s website at ir.changehealthcare.com.

    Non-GAAP Financial Information

    This press release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (“GAAP”). A reconciliation of the non-GAAP financial information to the most directly comparable GAAP financial measure is included with the above earnings per share disclosure.

    Cautionary Statement Regarding Forward-Looking Statements

    This press release may contain statements, estimates, projections or guidance that constitute “forward-looking statements” as defined under U.S. federal securities laws about the proposed transaction. Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “plan,” “project,” “should,” “will” and similar expressions identify forward-looking statements, which generally are not historical in nature. These statements are based on current plans, estimates and expectations that are subject to risks and uncertainties. We caution that actual results could differ materially from expected results, depending on the outcome of certain factors, including (i) the failure to satisfy the conditions to the completion of the proposed transaction, including approval of the proposed transaction by CHNG’s stockholders and the receipt of regulatory approvals on the terms expected or on the anticipated schedules; (ii) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement; (iii) there may be a material adverse change regarding CHNG or its business; (iv) the failure to complete or receive the anticipated benefits from the proposed transaction, including due to the failure to successfully integrate the businesses and technologies; (v) revenues following the proposed transaction may be lower than expected; (vi) operating costs, customer loss and business disruption (including, without limitation, difficulties in maintaining relationships with employees, customers, clients or suppliers) may be greater than expected; (vii) the retention of certain key employees at CHNG; (viii) the parties’ ability to meet expectations regarding the timing, completion and accounting and tax treatments of the proposed transaction; (ix) risks related to diverting management attention from ongoing business operations; (x) the risk that any regulatory approval, consent or authorization that may be required for the proposed transaction is not obtained or is obtained subject to conditions that are not anticipated; (xi) the outcome of any legal proceedings that may be instituted against UNH or CHNG related to the proposed transaction; (xii) there may be changes in economic conditions, financial markets, interest rates, political conditions or changes in federal or state laws or regulations; (xiii) there may be changes in the market price of CHNG’s common stock; (xiv) risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic; and (xv) the other factors relating to UNH and CHNG discussed in “Risk Factors” in their respective Annual Reports on Form 10-K for the most recently ended fiscal year and in their other filings with the Securities Exchange Commission (SEC), which are available at http://www.sec.gov. The effects of the COVID-19 pandemic may give rise to risks that are currently unknown or amplify the risks associated with many of these factors. Neither UNH nor CHNG assumes any obligation to update or revise this communication as a result of new information, future events or otherwise, except as otherwise required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.

    Participants in Solicitation

    Change Healthcare and its directors and executive officers, and UnitedHealth Group and its directors and executive officers, are deemed to be participants in the solicitation of proxies from stockholders of Change Healthcare in connection with the proposed merger. Information about Change Healthcare’s directors and executive officers and their ownership of Change Healthcare’s common stock can be found in its Annual Report on Form 10-K for the year ended March 31, 2020 filed with the SEC on June 4, 2020, in its Definitive Proxy Statement for its 2020 Annual Meeting of Stockholders filed with the SEC on July 16, 2020 and on Change Healthcare’s website at www.changehealthcare.com. Information about UnitedHealth Group’s directors and executive officers can be found in its Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 14, 2020, in its Definitive Proxy Statement for its 2020 Annual Meeting of Stockholders filed with the SEC on April 17, 2020 and on UnitedHealth Group’s website at http://www.unitedhealthgroup.com. Investors may obtain additional information regarding the interest of such participants by reading the proxy statement and other materials to be filed with the SEC in connection with proposed merger when they become available.

    Get the next $UNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UNH
    $CHNG

    CompanyDatePrice TargetRatingAnalyst
    UnitedHealth Group Incorporated
    $UNH
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    UnitedHealth Group Incorporated
    $UNH
    4/21/2025Buy → Hold
    Argus
    UnitedHealth Group Incorporated
    $UNH
    1/10/2025$595.00Hold → Buy
    HSBC Securities
    UnitedHealth Group Incorporated
    $UNH
    1/6/2025$625.00 → $610.00Buy
    Truist
    UnitedHealth Group Incorporated
    $UNH
    10/17/2024Buy → Hold
    HSBC Securities
    UnitedHealth Group Incorporated
    $UNH
    10/11/2024$675.00Overweight
    KeyBanc Capital Markets
    UnitedHealth Group Incorporated
    $UNH
    7/17/2024$555.00 → $615.00Outperform
    RBC Capital Mkts
    UnitedHealth Group Incorporated
    $UNH
    7/17/2024$481.00 → $647.00Hold → Buy
    Jefferies
    More analyst ratings

    $UNH
    $CHNG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Flynn Timothy Patrick was granted 180 shares, increasing direct ownership by 2% to 9,123 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      4/3/25 4:54:06 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Noseworthy John H was granted 180 shares, increasing direct ownership by 3% to 5,763 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      4/3/25 4:53:55 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Mcnabb Frederick William Iii was granted 183 shares, increasing direct ownership by 1% to 13,656 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      4/3/25 4:53:44 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    $CHNG
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by UnitedHealth Group Incorporated

      SCHEDULE 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      5/7/25 10:07:23 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Incorporated filed SEC Form 8-K: Leadership Update

      8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      4/29/25 4:02:36 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form DEFA14A filed by UnitedHealth Group Incorporated

      DEFA14A - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      4/21/25 4:06:26 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    $CHNG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/13/24 5:16:09 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/24 10:05:20 AM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/23 12:39:51 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    $CHNG
    Financials

    Live finance-specific insights

    See more

    $UNH
    $CHNG
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $UNH
    $CHNG
    Leadership Updates

    Live Leadership Updates

    See more
    • UnitedHealth Group Reports First Quarter 2025 Results and Revises Full Year Guidance

      Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 UnitedHealth Group (NYSE:UNH) reported first quarter 2025 results and revised its outlook for the year. "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well

      4/17/25 5:55:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • AM Best Affirms Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries

      AM Best has affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long- and Short-Term Issuer Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). Concurrently, AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) is stable. (See link below for a detailed listing of the companies and ratings.) The ratings reflect UnitedHealthcare's balance sheet strength, wh

      3/12/25 4:20:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

      The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.10 per share, to be paid on March 18, 2025, to all shareholders of record of UNH common stock as of the close of business March 10, 2025. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health b

      2/24/25 6:50:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • CareXM adds Home-Based Care Industry Leader, Carla Davis, to its Board of Directors

      CareXM, the leading provider of clinical triage and virtual care coordination solutions for post-acute care, announced today that Carla Davis has been appointed as an independent member of its Board of Directors, effective May 6, 2025. Davis joins the Board following an impressive 30-year career in home health and hospice, serving most recently as Senior Vice President of Hospice Operations at LHC Group. "We are excited to welcome Carla to CareXM's Board of Directors," said Si Luo, chief executive officer at CareXM. "Carla was one of the first customer leaders I had the privilege of meeting after joining CareXM, and from our first conversation, her unwavering commitment to advancing the pa

      5/7/25 8:46:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Reports First Quarter 2025 Results and Revises Full Year Guidance

      Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 UnitedHealth Group (NYSE:UNH) reported first quarter 2025 results and revised its outlook for the year. "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well

      4/17/25 5:55:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Announces Earnings Release Date

      UnitedHealth Group (NYSE:UNH) will release its first quarter 2025 financial results on Thursday, April 17, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company's website (www.unitedhealthgroup.com). The replay will be available through May 1 on the website. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technol

      3/24/25 6:50:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • Charlie Baker Joins UnitedHealth Group's Board of Directors

      UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos

      11/3/23 4:00:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • DNAnexus Announces Appointment of Thomas Laur as CEO

      Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief Executive Officer and member of the company's Board of Directors, effective September 11, 2023. Mr. Laur succeeds Richard Daly, who has overseen the company's significant growth since 2013 and will remain an active advisor and a member of the Board of Directors. "It has been the greatest privilege of my life to have led the evol

      9/12/23 9:02:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • Tactile Medical Appoints Elaine Birkemeyer as Chief Financial Officer

      MINNEAPOLIS, March 14, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Elaine Birkemeyer to the position of Chief Financial Officer, effective March 20, 2023. Ms. Birkemeyer will succeed Brent Moen, who is retiring. "Elaine is a dynamic and purpose-driven leader with over 25 years of experience in finance, accounting, and business strategy, including extensive senior leadership experience at multiple Fortune 500 companies, leading large divisions within the healthcare, consumer and retail industries," said Da

      3/14/23 9:00:00 AM ET
      $BBY
      $SNBR
      $TCMD
      $TGT
      Consumer Electronics/Video Chains
      Consumer Discretionary
      Home Furnishings
      Medical/Dental Instruments

    $UNH
    $CHNG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UnitedHealth downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded UnitedHealth from Buy to Hold and set a new price target of $490.00

      4/22/25 7:23:13 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by Argus

      Argus downgraded UnitedHealth from Buy to Hold

      4/21/25 8:37:42 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth upgraded by HSBC Securities with a new price target

      HSBC Securities upgraded UnitedHealth from Hold to Buy and set a new price target of $595.00

      1/10/25 9:15:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    $CHNG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Flynn Timothy Patrick bought $511,575 worth of shares (1,000 units at $511.57) (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      1/22/25 4:05:59 PM ET
      $UNH
      Medical Specialities
      Health Care